When applied to the MPTP-induced PD model mice, LETX-VI improved parkinsonian behaviors of the mice, mitigated MPTP-induced α-synuclein upregulation and TH downregulation, and displayed protective effects on neurons particularly dopaminergic neurons. This evidence concerns the gene SNCA and Parkinson disease.